Director​/Sr. Director Regulatory CMC, Lilly Gene Therapy

Overview

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first.

We’re looking for people who are determined to make life better for people around the world.

Eli Lilly and Company is seeking a highly experienced and strategic Director/Senior Director,Regulatory CMC to lead and execute regulatory CMC strategies for our cutting-edge gene therapy portfolio. This role will be critical in shaping the regulatory path for novel gene therapies from early development through commercialization, ensuring compliance with global health authority requirements.

• Develop and implement comprehensive global regulatory CMC strategies for assigned gene therapy programs, including IND/CTA, BLA/MAA, and post-approval submissions.
• Lead and manage the preparation, authoring, and review of high-quality CMC sections for all regulatory submissions, ensuring scientific accuracy, clarity, and adherence to regulatory guidelines.
• Act as the primary regulatory CMC liaison with health authorities (e.g., FDA, EMA, PMDA) for assigned gene therapy projects, leading and facilitating interactions, teleconferences, and meetings.
• Provide expert regulatory CMC guidance and support to cross-functional development teams (e.g., R&D, Manufacturing, Quality, Clinical) throughout the product lifecycle.
• Proactively identify and assess regulatory CMC risks and opportunities, developing mitigation strategies and providing strategic recommendations to senior leadership.
• Stay current with evolving global regulatory requirements, guidelines, and industry best practices pertaining to gene therapies and advanced therapeutic medicinal products (ATMPs).
• Lead and mentor junior regulatory CMC professionals, encouraging a culture of excellence and continuous improvement.
• Contribute to the development and improvement of internal regulatory CMC processes, standards, and templates.
• Manage external consultants and contractors as needed to support regulatory CMC activities.

• Education:
  
  Bachelor's degree in a scientific discipline (e.g., Biochemistry, Molecular Biology, Chemistry, Pharmacy, Chemical Engineering) is required. An advanced degree (MS, Ph.D.) is strongly preferred.
• Experience:
• 5+ years of expertise in regulatory CMC for gene therapy, cell therapy, or other advanced therapeutic medicinal products (ATMPs).
• 5+ years of experience with global regulatory submissions (e.g., IND/CTA, BLA/MAA) and interactions with major health authorities (FDA, EMA, etc.).

• In-depth knowledge of global regulatory requirements and guidelines for biologics and ATMPs (e.g., ICH, FDA, EMA)
• Strong scientific understanding of gene therapy technologies, manufacturing processes, and analytical methods.
• Excellent written and verbal communication skills, with the ability to articulate complex scientific and regulatory concepts clearly and concisely.
• Proven leadership and interpersonal skills, with the ability to influence and collaborate effectively with diverse cross-functional teams and external stakeholders.
• Strategic thinker with strong problem-solving and decision-making abilities.
• Ability to manage multiple projects simultaneously in a fast-paced and dynamic environment.
• Proficiency in regulatory information management systems and Microsoft Office Suite.

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form () for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.

Lilly is…